Get your driving records online. You can easily request a driverâs abstract, an insurance and claims history record or a commercial driving record (National Safety Code abstract) for your employer through our online application form. You will receive your driving record and/or insurance and claims history by email.
MusclePharm issued a total of 1,500,000 shares of its Series D Convertible Preferred Stock in a registered direct offering at a price of $8.00 per share. Each share of Series D Convertible Preferred Stock is convertible into two shares of common stock, subject to adjustment.
Marathon Pharma will pause launch of Duchenne muscular dystrophy drug after outcry over $89,000 price. 1  Marathon Pharmaceuticals said it would pause the launch of its recently-approved Duchenne muscular dystrophy drug after an outcry over Emflaza's $89,000-a-year price tag. The privately-held company said it has heard concerns about the drug's pricing and reimbursement details from the DMD community.